Written by Hemant Khanna
In recent months, even as our attention has been focused on the coronavirus outbreak, there have been a slew of scientific breakthroughs in treating diseases that cause blindness.
Researchers at U.S.-based Editas Medicine and Ireland-based Allergan …
Written by Paige Minemyer
CVS Health is the latest company to launch a solution aimed at helping employers and university campuses safely reopen amid COVID-19.
The Return Ready solution offers employers and colleges the ability to customize a testing and …
Written by Eric Sagonowsky
In the high-stakes patent fight between Biogen and Mylan over Tecfidera’s main remaining patent, Mylan has scored a major win in federal court.
U.S. District Judge Irene Keeley said Mylan “demonstrated by clear and convincing evidence” that …
Sourced from Pear Therapeutics
BOSTON and SAN FRANCISCO, June 18, 2020 — Pear Therapeutics, Inc. today announced that the Health Science Authority (HSA) of Singapore has authorized reSET® for the treatment of adults with substance use disorder (SUD) in that country. This …
Sourced from Akili Interactive
BOSTON, Mass – June 15, 2020 – Akili today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for EndeavorRxTM (AKL-T01) as a prescription treatment for children with attention-deficit/hyperactivity disorder (ADHD). Delivered through a captivating video game experience, EndeavorRx is indicated …
Peter Decotis, MSBA Program 
Todd Bartlett, MSMS Program 
